| Literature DB >> 28962584 |
Abstract
BACKGROUND: Sphingobacterium spiritivorum is a glucose non-fermenting Gram-negative rod, formerly classified as one of the Flavobacterium species. It is characterized by a large number of cellular membrane sphingophospholipids. Sphingobacterium species are ubiquitous and isolated from natural environments, such as soil and water. However, they rarely cause infections in humans. Only a limited number of cases have been reported in elderly and immunocompromised patients with underlying diseases and predisposing factors. CASEEntities:
Keywords: Bacteremia; Cellulitis; Sphingobacterium spiritivorum
Mesh:
Substances:
Year: 2017 PMID: 28962584 PMCID: PMC5622497 DOI: 10.1186/s13256-017-1445-6
Source DB: PubMed Journal: J Med Case Rep ISSN: 1752-1947
Fig. 1Appearance of lower extremities of the patient on the day of admission (a) and after treatment (b). On the day of admission, reddening and swelling were observed on the left leg. Dermatophyte was positive in the toe webs as per a potassium hydroxide test
Fig. 2Gram stain of the organism isolated from blood culture (magnification, ×1000). Gram-negative short rods were seen
Antibiotics sensitivity of Sphingobacterium spiritivorum isolated from the present case
| Antibiotics | Minimal inhibitory concentration (μg/mL) | Sensitivity |
|---|---|---|
| Piperacillin | 16 | S |
| Cefoperazone | 32 | I |
| Ceftazidime | ≤4 | S |
| Cefepime | 4 | S |
| Latamoxef | >32 | R |
| Imipenem/cilastatin | ≤1 | S |
| Meropenem | ≤1 | S |
| Piperacillin/tazobactam | 8 | S |
| Aztreonam | >16 | R |
| Amikacin | >32 | R |
| Tobramycin | >8 | R |
| Gentamycin | >8 | R |
| Minocycline | ≤1 | S |
| Trimethoprim/sulfamethoxazole | ≤20 | S |
| Levofloxacin | ≤1 | S |
| Ciprofloxacin | ≤0.5 | S |
I intermediate, R resistant, S susceptible
Previously reported five cases of Sphingobacterium spiritivorum infections and the present case
| Case number and Reference | Reported year | Age/Sex | Underlying diseases and predisposing factors | Source of isolation | Diagnosis | Antibiotics | Clinical outcome |
|---|---|---|---|---|---|---|---|
| Case 1 [ | 2002 | 72/M | Parkinson’s disease | Blood | Cellulitis | Cefazolin followed by ampicillin/sulbactam | Complete recovery |
| Case 2 [ | 2003 | 84/M | Refractory anemia | Blood | Cellulitis | Amoxicillin/clavulanate | Complete recovery |
| Case 3 [ | 2013 | 68/F | Acute myeloid leukemia treated with chemotherapy | Blood | CRBSI | Cefepime followed by ciprofloxacin | Died |
| Case 4 [ | 2016 | 80/F | ESRD on hemodialysis via tunneled central venous dialysis catheter; DM | Blood | CRBSI | Trimethoprim followed by meropenem and ciprofloxacin | Complete recovery |
| Case 5 [ | 2016 | 89/M | Parkinson’s disease; skin tears and abrasion due to multiple falls | Blood | Cellulitis | Piperacillin/tazobactam followed by amoxicillin/clavulanate | Complete recovery |
| The present case | 2017 | 80/M | COPD; edema due to CHF; tinea pedis | Blood | Cellulitis | Meropenem followed by levofloxacin | Complete recovery |
CHF congestive heart failure, COPD chronic obstructive pulmonary disease, CRBSI catheter-related blood stream infection, DM diabetes mellitus, ESRD end-stage renal disease, F female, M male